🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of uncertain source.

Several professionals stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and consumer laws, risking fines, legal action or prison.

Service Reaction and Content Elimination

Based on the social media company, the platform has removed violative material and banned associated hashtags and query recommendations. The organization stated it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After moments of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Product Details and Pricing

Inside these groups, posts display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to potentially significant medical dangers”.